MET and cancer: Unlike the concept of “oncogene addiction,” where the oncogene is a primary driver, the inappropriate activation of MET leading to “oncogene expedience” is a result, rather than the cause, of the transformed phenotype, and may facilitate the cancer’s progression to metastatic spreading.